Opus Bio

Biopharmaceutical start-up companies – firms founded four years ago or less – raised fewer dollars during the third quarter than during the prior quarter despite Roivant Sciences GMBH 's massive $1

Below is Scrip’s monthly roundup, compiled by Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. For Phil Robilotto, v

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

In Vitro Diagnostics Gen-Probe Inc. University of Michigan Gen-Probe and Univ. of MI test for prostate cancer markers May — Gen-Probe (nucleic acid testing for diagnostics) licensed exclusive worldw